RU2013103733A - PHARMACEUTICAL COMPOSITION OF ANTI-VIRAL ACTION - Google Patents
PHARMACEUTICAL COMPOSITION OF ANTI-VIRAL ACTION Download PDFInfo
- Publication number
- RU2013103733A RU2013103733A RU2013103733/15A RU2013103733A RU2013103733A RU 2013103733 A RU2013103733 A RU 2013103733A RU 2013103733/15 A RU2013103733/15 A RU 2013103733/15A RU 2013103733 A RU2013103733 A RU 2013103733A RU 2013103733 A RU2013103733 A RU 2013103733A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- carbomer
- composition according
- hyporamine
- glycerin
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Фармацевтическая композиция, обладающая противовирусным и противовоспалительным действием, содержащая терапевтически эффективное количество гипорамина и целевые добавки, отличающаяся тем, что в качестве целевых добавок содержит, карбомер, глицерин, масло вазелиновое, кислоту сорбиновую, полисорбат и воду при следующем соотношении компонентов, г:Гипорамин 0,5Карбомер 1,0-1,5Триэтаноламин 1,3-1,5Глицерин 9,0-10,0Твин-80 1,0-1,3Масло касторовое 9,0-10,0Кислота сорбиновая 0,2-0,3Вода очищенная до 100,02. Фармацевтическая композиция по п.1, отличающаяся тем, что в качестве смягчающего агента используют масло вазелиновое.3. Фармацевтическая композиция по п.1 или 2, отличающаяся тем, что в качестве карбомера она содержит карбомер 940 или карбомер 980.4. Фармацевтическая композиция по п.1 или 2, отличающаяся тем, что в качестве консерванта в лекарственную форму введен нипагин.1. A pharmaceutical composition having antiviral and anti-inflammatory effects, containing a therapeutically effective amount of hyporamine and target additives, characterized in that it contains carbomer, glycerin, liquid paraffin, sorbic acid, polysorbate and water in the following ratio, g: Hyporamine 0.5 Carbomer 1.0-1.5 Triethanolamine 1.3-1.5 Glycerin 9.0-10.0 Tween-80 1.0-1.3 Castor oil 9.0-10.0 Sorbic acid 0.2-0.3 Water purified to 100.02. The pharmaceutical composition according to claim 1, characterized in that vaseline oil is used as a softening agent. The pharmaceutical composition according to claim 1 or 2, characterized in that as carbomer it contains carbomer 940 or carbomer 980.4. The pharmaceutical composition according to claim 1 or 2, characterized in that nipagin is introduced into the dosage form as a preservative.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013103733/15A RU2538082C2 (en) | 2013-01-29 | 2013-01-29 | Antiviral pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013103733/15A RU2538082C2 (en) | 2013-01-29 | 2013-01-29 | Antiviral pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013103733A true RU2013103733A (en) | 2014-08-10 |
RU2538082C2 RU2538082C2 (en) | 2015-01-10 |
Family
ID=51354808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013103733/15A RU2538082C2 (en) | 2013-01-29 | 2013-01-29 | Antiviral pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2538082C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2596499C1 (en) * | 2015-10-29 | 2016-09-10 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" (ФГБНУ ВИЛАР) | Pharmaceutical composition of antiviral and anti-inflammatory action |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2118163C1 (en) * | 1994-04-27 | 1998-08-27 | Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" | Drug for treatment of patients with viral disease |
RU2200570C1 (en) * | 2002-02-26 | 2003-03-20 | Быков Валерий Алексеевич | Complex of natural compounds of vegetable origin eliciting spermatocidal effect and activity with regards to infections transferred by sexual way |
-
2013
- 2013-01-29 RU RU2013103733/15A patent/RU2538082C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2538082C2 (en) | 2015-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591003A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
TR201904455T4 (en) | 1,2,4-triazoles and their uses as nuclear transport modulators. | |
RU2016135431A (en) | COMPOSITION FOR LOCAL TREATMENT OF THE RAS | |
EA201690287A1 (en) | 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY | |
RU2015141767A (en) | Compositions and methods for the local delivery of prostaglandins to subcutaneous fat | |
NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
BR112015025172A2 (en) | pharmaceutical composition | |
MA43918A (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF ATOPIC DERMATITIS CONTAINING AN IL-31 ANTAGONIST AS ACTIVE SUBSTANCE | |
HRP20180316T1 (en) | Isolated solid form of anamorelin monohydrochloride with low molar ratio of chloride:anamolerin and low content of residual organic solvent | |
EA201492091A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION CONTAINING TERBINAPHID AND UREA | |
RU2015109566A (en) | NEW EXTRACTS FROM CYNARA SCOLYMUS, COFFEA spp. AND OLEA EUROPAEA FOR THE TREATMENT OF A METABOLIC SYNDROME | |
EA201590475A1 (en) | TETRACYCLINE CONNECTIONS | |
MY167777A (en) | A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site | |
EA201690854A1 (en) | PHARMACEUTICAL COMPOSITIONS WITH HYDRATING AND LUBRICATING ACTION | |
BR112017017643A2 (en) | topical pharmaceutical formulation | |
TR201909029T4 (en) | Stable compositions for storage containing rifaximin alpha. | |
RU2013103733A (en) | PHARMACEUTICAL COMPOSITION OF ANTI-VIRAL ACTION | |
EA201691825A1 (en) | STABILIZED SOLUTION ON THE BASIS OF ACTIVE SUBSTANCES, METHOD FOR OBTAINING A STABILIZED SOLUTION OF ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION ON THE BASIS OF A STABILIZED SOLUTION OF ACTIVE SUBSTANCES (TWO OPTIONS) | |
EA202091561A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE LENALIDOMIDE SALT | |
EA201592297A1 (en) | AGOMELATIN COMPOSITIONS CONTAINING AGOMELATIN IN THE FORM OF CRYSTALS | |
EA201791191A1 (en) | WATER PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION IN THE ORAL CAVITY CONTAINING FLURBIPROPHENE AND DEXPANTENOL | |
RU2012135798A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SKIN ITCH | |
RU2013105211A (en) | APPLICATION OF TERAPEPTIDE Arg-Pro-Gly-Pro AS A MEANS FOR PREVENTION AND TREATMENT OF HYPERCHOLESTERINEMIA, METHOD FOR PREVENTION AND TREATMENT OF HYPERCHOLESTEREMIA, PHARMACEUTICAL CHEMISTROSIS | |
RU2012144920A (en) | COMPOSITION FOR PREPARATION OF A PREPARED PROLONGED MEDICINAL FORM | |
BR112015014180A2 (en) | gel compositions |